Bionik Laboratories Corp. Quarterly Lessee, Operating Lease, Liability, to be Paid in USD from Q3 2022 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Bionik Laboratories Corp. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q3 2022 to Q1 2023.
  • Bionik Laboratories Corp. Lessee, Operating Lease, Liability, to be Paid for the quarter ending March 31, 2023 was $330K.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $330K Mar 31, 2023 10-K 2023-06-21
Q4 2022 $339K Dec 31, 2022 10-Q 2023-02-08
Q3 2022 $348K Sep 30, 2022 10-Q 2022-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.